Consistently, both the GEPIA2.0 and Sangerbox databases predicted that mRNA expression of GPX4 was correlated with short overall survival (OS) in patients with COAD (Fig. 1E; Fig. S1B). Here, GPX4 is linked to colon adenocarcinoma.